Tue, 4 Aug 2015
Starboard Discloses MedAssets Stake, Calls For Overhaul
StockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.
Competitive advantages improved for one health-care firm, while a spin-off at another narrowed its moat , says Morningstar's Paul Larson in his discussion on recent moat -rating upgrades and downgrades.
Recent rebalancing of Morningstar's Wide Moat Focus Index shows that quality stocks aren't nearly as cheap as they were this time last year.
Some energy names and out-of-favor companies joined the index, but, in a sign of the times, few deeply discounted stocks .
Investors have started to pay attention to risk again, but market valuations overall don't offer much margin of safety, says Morningstar's Matt Coffina.
It was a good year for wide - moat stocks overall, but Exxon, Amazon, and a few others lagged the market, says Morningstar markets editor Jeremy Glaser .
Morningstar's Heather Brilliant details our 10-year track record for stocks , particularly the strong outperformance of 5-star names with competitive advantages.
Morningstar's Heather Brilliant explains why investors should care about movement in market and sector correlations.
Morningstar StockInvestor editor Matt Coffina offers some of his new investment ideas following a quarterly rebalancing of the Wide Moat Focus Index.
In a fully valued market, there are worse things than buying wide - moat names at decent discounts.
Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.
Morningstar StockInvestor editor Matt Coffina explains why a fairly valued stock should outperform both cash and bonds over the long run.
©2014 Morningstar Advisor. All right reserved.